Gaël Paul Hammer

Gaël Paul Hammer

Auto-generated profile, based on publicly available information

Gaël Paul Hammer

National Center of Pathology (NCP), Laboratoire National de Santé (LNS), Dudelange, Luxembourg

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2014 in Radiation and Environmental Biophysics
Verified
Journal Article
Closed access
PDF file
HMHiltrud Merzenich
Hiltrud Merzenich
GHGaël P. Hammer
Gaël P. Hammer
KTKatrin Tröltzsch
Katrin Tröltzsch
KRKai Ruecker
Kai Ruecker
JBJohanna Buncke
Johanna Buncke
MBMaria Blettner
Maria Blettner

15 February 2025 in Acta Neuropathologica
Verified
Journal Article
Open access
PDF file
SFSonja Fixemer
Sonja Fixemer
MMMónica Miranda de la Maza
Mónica Miranda de la Maza
GHGaël Paul Hammer
Gaël Paul Hammer
FJFélicia Jeannelle
Félicia Jeannelle
SSSophie Schreiner
Sophie Schreiner
DBDavid S. Bouvier
David S. Bouvier
In Alzheimer’s disease (AD), microglia form distinct cellular aggregates that play critical roles in disease progression, including Aβ plaque-associated microglia (PaM) and the newly identified coffin-like microglia (CoM). PaM are closely associated with amyloid-β (Aβ) plaques, while CoM are enriched in the pyramidal layer of the CA2/CA1 hippocampal subfields, where they frequently engulf neurons and associate with tau-positive tangles and phosphorylated α-synuclein. To elucidate the role of these microglial subtypes, we employed high-content neuropathology, integrating Deep Spatial Profiling (DSP), multiplex chromogenic immunohistochemistry and confocal microscopy, to comprehensively map and characterise their morphological and molecular signatures, as well as their neuropathological and astrocytic microenvironments, in AD and control post-mortem samples. PaM and PaM-associated astrocytes exhibited signatures related to complement system pathways, ErbB signalling, and metabolic and neurodegenerative processes. In contrast, CoM displayed markers associated with protein degradation and immune signalling pathways, including STING, TGF-β, and NF-κB. While no direct association between CD8 + T cells and either microglial type was observed, CD163 + perivascular macrophages were frequently incorporated into PaM. These findings provide novel insights into the heterogeneity of microglial responses, in particular their distinct interactions with astrocytes and infiltrating immune cells, and shed light on specific neurodegenerative hotspots and their implications for hippocampal deterioration in AD.

19 February 2020 in Occupational and Environmental Medicine
Verified
Journal Article
Closed access
PDF file
SDSteffen Dreger
Steffen Dreger
DWDaniel Wollschläger
Daniel Wollschläger
TSThomas Schafft
Thomas Schafft
GHGaël P Hammer
Gaël P Hammer
MBMaria Blettner
Maria Blettner
HZHajo Zeeb
Hajo Zeeb
Objectives To determine cancer mortality compared with the general population and to examine dose-response relationships between cumulative occupational radiation dose and specific cancer outcomes in the German aircrew cohort. Methods For a cohort of 26 846 aircrew personnel, standardised mortality ratios (SMR) were calculated. Dose-response analyses were carried out using Poisson regression to assess dose-related cancer risks for the period 1960–2014. Exposure assessment comprises recently available dose register data for all cohort members and newly estimated retrospective cabin crew doses for 1960–2003. Results SMR for all-cause, specific cancer groups and most individual cancers were reduced in all aircrew groups. The only increases were seen for brain cancer in pilots (n=23, SMR 2.01, 95% CI 1.15 to 3.28) and for malignant melanoma (n=10, SMR 1.88, 95% CI 0.78 to 3.85). Breast cancer mortality among female cabin crew was similar to the general population (n=71, SMR 1.06, 95% CI 0.77 to 1.44). Overall median cumulative effective dose was 34.2 mSv (max: 116 mSv) for 1960–2014. No dose-response associations were seen in any of the models. For brain cancer, relative risks were elevated across dose categories. An indicative negative trend with increasing dose category was seen for large intestine cancer in female cabin crew (n=23). Conclusions There was no evidence for significant dose-response patterns for the considered cancer types. Interpretation of results remains difficult as cumulative dose is closely related to age. Future work should focus on investigating radiation jointly with other risk factors that may contribute to risks for specific cancers among aircrew.

6 July 2015 in Deutsches Ärzteblatt international
Verified
Journal Article
Closed access
GHGaël P. Hammer
Gaël P. Hammer
KEKatharina Emrich
Katharina Emrich
MNMichael Nasterlack
Michael Nasterlack
MBMaria Blettner
Maria Blettner
MYMei Yong
Mei Yong
In 2007 the International Agency for Research on Cancer (IARC) classified shift work involving circadian disruption as a probable human carcinogen (1). Most of the evidence for this is based on animal experiment models and only a few reliable...

1 October 2019 in Journal of Radiological Protection
Verified
Journal Article
Closed access
PDF file
DBDan Baaken
Dan Baaken
GHGaël P Hammer
Gaël P Hammer
MSMichael C Seidenbusch
Michael C Seidenbusch
KSKarl Schneider
Karl Schneider
CSClaudia Spix
Claudia Spix
ELEva Lorenz
Eva Lorenz
Studies on children exposed to ionising radiation by computed tomography (CT) indicate an increased risk of leukemia and central nervous system (CNS) tumors. Evidence of the risks associated with diagnostic x-ray examinations, the most frequent examination in pediatric radiology, in which the radiation dose is up to 750 times lower compared to CT examinations, is less clear. This study presents results of the second follow-up for the risk of childhood cancer in a cohort of children (<15 years) with diagnostic x-ray exposure at a large German hospital during 1976–2003 followed for additional 10 years until 2016. With a latency period of 6 months, 92 998 children contributed 794 549 person-years. The median effective dose was 7 μ Sv. Hundred incident cancer cases were identified: 35 leukemia, 13 lymphomas, 12 CNS tumors, 15 blastomas, 15 sarcomas and 10 other solid tumors, consisting of six germ cells tumors, three thyroid cancers and one adrenocortical carcinoma. For all cancer cases combined the standardised incidence ratio (SIR) was 1.14 (95% confidence interval (CI) 0.93–1.39), for leukemia 1.15 (95% CI 0.63–1.61), for lymphomas 1.03 (95% CI 0.55–1.76), for CNS tumors 0.65 (95% CI 0.34–1.14), for blastomas 1.77 (95% CI 0.91–2.91), for sarcomas 1.28 (95% CI 0.71–2.11) and for other solid tumors 2.38 (95% CI 1.14–4.38). Dose-response analysis using Poisson regression revealed no significant trend for dose groups. Results did not differ substantially with a latency period of 2 years for all cancer entities and 5 years for solid tumors in sensitivity analyses. Overall, the null results of the first follow-up were confirmed. Although an association between radiation exposure and a risk for certain solid tumors like thyroid cancer is known, the significantly increased SIR in the group of other solid tumors must be critically interpreted in the context of the small number of cases and the very low doses of radiation exposure in this group.

25 August 2008 in Deutsches Ärzteblatt international
Verified
Journal Article
Open access
JKJürgen Krämer
Jürgen Krämer
MBMaria Blettner
Maria Blettner
GHGael P. Hammer
Gael P. Hammer
Degenerative changes in the lumbar spine can cause back pain with or without radiation into the lower limb. The most common sufferers are middle-aged persons between the ages of 30 and 50, but the number of patients under age 30 is steadily rising....